In addition, maintaining diagnostic vigilance, including genetic testing for PRNP codon 129, and use of molecular diagnostics on biofluids taken in life in confirmed CJD cases, will help distinguish variant cases from sporadic CJD. The gene discussed is PRNP; the disease is Creutzfeldt Jacob disease.